Alkyl Amines Financial Statements

Alkyl Amines (ALKYLAMINE) reported revenue of ₹15.68B in FY2026 with net income of ₹1.80B. Total assets stood at ₹18.95B and free cash flow was ₹1.10B.

Alkyl Amines Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		16.02B	15.68B
Cost of Rev. Cost of Revenue		-8.39B	-8.19B
Gross Profit		7.63B	7.48B
SGA Sales, General & Admin		-4.42B	-4.32B
Op. Income Operating Income		2.50B	2.45B
PBT Profit Before Tax		2.49B	2.43B
Net Income		1.86B	1.80B
Dil. Shares Diluted Shares		51.34M	51.21M
Diluted EPS		36.25	35.15

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Alkyl Amines's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Alkyl Amines Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		6.30B	6.73B
Non-curr. assets Total non-current assets		11.59B	12.23B
Total assets		17.89B	18.95B
Curr. liabilities Total current liabilities		2.45B	2.16B
Non-curr. liab. Total non-current liabilities		1.41B	1.46B
Total liabilities		3.86B	3.62B
Total equity		14.02B	15.33B
Total liab. & eq. Total liabilities & equity		17.89B	18.95B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Alkyl Amines's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Alkyl Amines Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		2.49B	2.43B
Operating CF Cash flow Operating Activities		2.63B	2.39B
Capex Investments in PPE		-476.88M	-1.28B
Investing CF Cash flow Investing Activities		-1.96B	-1.37B
Dividend Paid		-511.31M	-511.41M
Financing CF Cash flow Financing Activities		-491.61M	-560.80M
Cash (start) Cash at beginning of period		303.71M	487.79M
Cash (end) Cash at end of period		487.79M	941.53M
FCF Free Cash Flow		2.15B	1.10B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Alkyl Amines's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026